Peptide immunogens of IL-31 and formulations thereof for the treatment and/or prevention of atopic dermatitis
CA3087036A1
Peptide immunogens and formulations thereof targeting membrane-bound ige for treatment of ige mediated allergic diseases
JP2017141234A
Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (prrs)
EP3191119A1
Immunogenic lhrh composition and use thereof in pigs
TW201700497A
Peptide vaccine for prevention and immunotherapy of dementia of the alzheimer's type
US2014271690A1
Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type
KR20150084993A
Synthetic peptide-based emergency vaccine against foot and mouth disease (fmd)
CA2890678A1
Synthetic peptide-based emergency vaccine against foot and mouth disease (fmd)
MX2014007894A
Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (prrs).
TW201247874A
Method for producing the activity of bone activating protein
KR20130041185A
Designer peptide-based pcv2 vaccine
WO2005047308A2
Peptide-based diagnostic reagents for sars
BR0307724A
stabilized synthetic immunogen delivery systems
US7501494B2
Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection
US6906169B2
Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
US6780969B2
Synthetic peptide composition as immunogens for prevention of urinary tract infection
AU4826799A
Synthetic somatostatin immunogen for growth promotion in farm animals
TWI227241B
IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate
TWI229679B
Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
US6107021A
Synthetic peptide vaccines for foot-and-mouth disease
